Viewing StudyNCT03207178


Ignite Creation Date: 2025-12-18 @ 9:37 AM
Ignite Modification Date: 2025-12-18 @ 9:37 AM
Study NCT ID: NCT03207178
Status: None
Last Update Posted: 2017-07-02 00:00:00
First Post: 2017-06-23 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Sequential Infusion of Anti-CD19 and Anti-CD20 CAR-T Cells Against Relapsed and Refractory B-cell Lymphoma
Sponsor:
Organization: